Careers
Trial Participants
Investors
Submit an RFP
Choose Language
Search
Scientific Expertise
Scientific Expertise >
Therapeutic Areas
Therapeutic Areas >
Cardiovascular
Dermatology
Diabetes and Endocrinology
Hepatology
Infectious Disease
Inflammation
Nephrology
Neuroscience
Oncology
Ophthalmology
Respiratory & Pulmonary
Rheumatoid Arthritis
Specialty Areas
Specialty Areas >
Cell and Gene Therapies
Pediatrics
Rare Diseases
Global Solutions
Global Solutions >
Clinical Development
Clinical Development >
Early: Phase I / IIa
Late: Phase IIb / III
Real-World Evidence and Post-Approval Studies
Decentralized Clinical Trials
Data Analysis & Reporting
Clinical Trial Project Management & Monitoring
Patient Safety & Pharmacovigilance
Clinical Pharmacology
Clinical Pharmacology >
Clinical Research Units (CRUs)
Drug Development Consulting
Drug Development Consulting >
Market Access & HEOR Strategy
Regulatory Strategy Consulting
Product Development Team
Enabling Technologies
Enabling Technologies >
Mobile Clinical Services
Full and Functional Service Provider Models
Full and Functional Service Provider Models >
Hub and Patient Access Support
Hub and Patient Access Support >
Specialty Pharmacy
Device and Diagnostic Development
Device and Diagnostic Development >
Our Customers
Our Customers >
Pharmaceutical
Pharmaceutical >
Biotechnology
Biotechnology >
Med Tech
Med Tech >
About Us
About Us >
Blog
Blog >
Promoting access to innovative cardiac medical devices through diversity and inclusion
SGLT2 inhibitors as renoprotective agents for pediatric patients living with chronic kidney disease
Five ways Fortrea's new Shanghai office is promoting sustainability and environmental stewardship
Locations
Locations >
Investors
Investors >
Leadership
Leadership >
Newsroom
Newsroom >
Contact Us
Back
Blog: Fresh insights driving agile collaboration
Home
/
About Us
/
Blog
Five ways Fortrea's new Shanghai office is promoting sustainability and environmental stewardship
Read more
about Five ways Fortrea's new Shanghai office is promoting sustainability and environmental stewardship
SGLT2 inhibitors as renoprotective agents for pediatric patients living with chronic kidney disease
Read more
about SGLT2 inhibitors as renoprotective agents for pediatric patients living with chronic kidney disease
Promoting access to innovative cardiac medical devices through diversity and inclusion
Read more
about Promoting access to innovative cardiac medical devices through diversity and inclusion
Key takeaways from the 2023 SCDM AC & Leadership Forum
Read more
about Key takeaways from the 2023 SCDM AC & Leadership Forum
Standardizing cosmetovigilence
Read more
about Standardizing cosmetovigilence
Advancing cell and gene therapy frontiers
Read more
about Advancing cell and gene therapy frontiers
Patient safety in clinical trials
Read more
about Patient safety in clinical trials
Leveraging precision medicine to advance clinical trials in Latin America
Read more
about Leveraging precision medicine to advance clinical trials in Latin America
Fix, replace or augment: Key considerations for rescue or transition studies in medical device clinical trials
Read more
about Fix, replace or augment: Key considerations for rescue or transition studies in medical device clinical trials